Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05556356
Other study ID # IU15386
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date September 13, 2022
Est. completion date September 2024

Study information

Verified date September 2023
Source Indiana Hand to Shoulder Center
Contact Lexie Reissaus, CCRP
Phone 317-471-4312
Email lreissaus@ihtsc.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Basilar thumb arthritis is a common problem that affects 7% of men and 15% of women. It is regarded as one of the more painful procedures commonly performed by hand surgeons. Opioid overuse and diversion are significant problems in the country that contribute to opioid addiction as well as deaths from opioid overdose. Prior studies have examined the effect of different nerve block compositions on perioperative and postoperative analgesia, but none have looked at perioperative loading analgesia. We will attempt to address this problem by exploring alternative analgesia regimens to decrease opioid prescribing after 1st carpometacarpal (CMC) joint arthroplasty.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date September 2024
Est. primary completion date May 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults (18 years of age or older) - Patients presenting with symptomatic 1st CMC arthritis with or without scaphotrapeziotrapezoid arthritis - Eaton Classification stage II, III, or IV OA of the first CMC joint based on xrays - Patients who plan to undergo a ligament reconstruction and tendon interposition (LRTI) or thumb suspensionplasty procedure within 6 months of enrolling to study - Bilateral thumbs included Exclusion Criteria: - <18 years age - Prior surgical history of ipsilateral 1st CMC arthroplasty or procedures involving thumb CMC joints - Prior ipsilateral tendon rupture or ipsilateral peripheral nerve palsy - History of opioid dependency or current chronic opioid use - Contraindication to acetaminophen use - Contraindication to NSAID use - Contraindication or known allergy to peripheral nerve blockade, including coagulopathy - Contraindication to supraclavicular block due to anatomic variability or inability to tolerate phrenic nerve blockade. - Contraindication to multivitamin use - Liver dysfunction

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Acetaminophen
pre-operative acetaminophen (1000mg)
Other:
Placebo: Multivitamin
pre-operative Multivitamin

Locations

Country Name City State
United States Indiana Hand to Shoulder Center Indianapolis Indiana

Sponsors (1)

Lead Sponsor Collaborator
Indiana Hand to Shoulder Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale (VAS) Patients report pain on a scale of 0 (no pain) to 100 (worst possible pain) 2 weeks
Primary Number of Narcotic Pills Used Number of Narcotic Pills Used 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT00198029 - An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study N/A
Enrolling by invitation NCT06171529 - Efficacy of a Single Injection of CTM for Post-Operative CMC Arthritis N/A
Not yet recruiting NCT04588961 - Trapeziectomy Suspensionplasty Versus Carpometacarpal Joint Replacement in Treatment of Basal Thumb Osteoarthritis N/A
Recruiting NCT04104477 - Thumb Osteoarthritis Mechanisms N/A